prismCDX

prismCDX is a South Korea-based private healthcare diagnostics and translational research company focused on immune monitoring, companion diagnostics, and biomarker analysis for precision medicine. The company markets services and platform capabilities spanning multiplex immunohistochemistry, ultra-sensitive ELISA, and CyTOF-based immune profiling to support tumor microenvironment characterization and immunotherapy decision-making. prismCDX also states that it is developing early diagnostic and companion diagnostic kits for applications including oncology, Alzheimer's disease, prostate cancer, and cardiovascular disease. In addition to diagnostics development, the company has positioned itself as a specialized CRO serving translational and clinical research programs for biopharma partners.